Therapeutic Area market research reports by GlobalData

• Female Sexual Dysfunction (FSD) - Competitive Landscape

  Feb 29, 2024  |  Published by: GlobalData  |  USD 3,495

  Female Sexual Dysfunction (FSD) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FSD therapeutics. More than 384,000,000 total prevalent cases of FSD were there in 2023 in the 16 countries covered in GlobalData’s epidemio ... Read More

• Orthodontic Materials and Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Feb 27, 2024  |  Published by: GlobalData  |  USD 2,500

  Orthodontic Materials and Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Orthodontic Materials and Products Pipeline Report including Stages of Development, ... Read More

• Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Feb 27, 2024  |  Published by: GlobalData  |  USD 4,000

  Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Regi ... Read More

• Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024 provides an overview of Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data rela ... Read More

• Endometriosis - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Endometriosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Endometriosis - Global Clinical Trials Review, 2024 provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Re ... Read More

• Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 provide ... Read More

• Ewing Sarcoma - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Ewing Sarcoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2024 provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Re ... Read More

• Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024

  Feb 20, 2024  |  Published by: GlobalData  |  USD 2,500

  Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This r ... Read More

• Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032

  Feb 16, 2024  |  Published by: GlobalData  |  USD 3,995

  Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032 Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases (National Cancer Institute, 2020). NSCLC begins when healthy cells that make up the lining of ... Read More

• DTx in Medical - Thematic Research

  Feb 15, 2024  |  Published by: GlobalData  |  USD 995

  DTx in Medical - Thematic Research Summary Digital therapeutics (DTx) are software-based interventions that deliver evidence-based therapeutic interventions to patients. The interventions are driven by high-quality software programs to prevent, manage, or treat a medical condition. DTx can be prescr ... Read More

• Premature Labor (PL) -Competitive Landscape

  Feb 12, 2024  |  Published by: GlobalData  |  USD 3,495

  Premature Labor (PL) -Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PL therapeutics. More than 5,000,000 total prevalent cases of PL are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology foreca ... Read More

• Ovarian Cancer Opportunity Assessment and Forecast

  Feb 08, 2024  |  Published by: GlobalData  |  USD 9,995

  Ovarian Cancer Opportunity Assessment and Forecast Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Ovarian Cancer. These sales fo ... Read More

• Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

  Jan 31, 2024  |  Published by: GlobalData  |  USD 7,500

  Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize qu ... Read More

• Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024 provides an overview of Idiopathic Pulmonary Fibrosis Clinical trials scenario. This report provides top line data rela ... Read More

• Glaucoma - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Glaucoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Glaucoma - Global Clinical Trials Review, 2024 provides an overview of Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Glaucoma. Report includes an ove ... Read More

• Cervical Cancer - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Cervical Cancer - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cervical Cancer - Global Clinical Trials Review, 2024 provides an overview of Cervical Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Ca ... Read More

• Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024

  Jan 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report pro ... Read More

• mRNA Vaccines in Infectious Diseases Market Overview

  Dec 31, 2023  |  Published by: GlobalData  |  USD 995

  mRNA Vaccines in Infectious Diseases Market Overview Summary The report provides an assessment of the mRNA vaccines space, including History of mRNA Therapeutics Development, Industry Trends, Marketed Products, Pipeline Product, Opportunities, Challenges, and Unmet Needs, Current Companies and Brief ... Read More

• Acute Ischemic Stroke (AIS) - Competitive Landscape

  Dec 30, 2023  |  Published by: GlobalData  |  USD 3,495

  Acute Ischemic Stroke (AIS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AIS therapeutics. More than 90,000,000 diagnosed prevalent cases of AIS are anticipated in 2023 in the 16 countries covered in GlobalData’s epid ... Read More

• Thematic Intelligence - Biosimilars in oncology

  Dec 29, 2023  |  Published by: GlobalData  |  USD 7,995

  Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More

• Rheumatoid Arthritis (RA) - Competitive Landscape

  Dec 21, 2023  |  Published by: GlobalData  |  USD 3,495

  Rheumatoid Arthritis (RA) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RA therapeutics. More than 13 million diagnosed prevalent cases of RA are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemio ... Read More

• Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More

• Gallbladder Cancer - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More

• Hepatocellular Carcinoma - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ... Read More

• Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Chronic ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >